|
Factors
|
No. of patients
|
Overall survival (OS)
|
Disease-free survival (DFS)
|
|---|
|
5-year OS rate (%)
|
P value
|
5-year DFS rate (%)
|
P value
|
|---|
|
Age
|
|
< 55 y/o
|
83
|
48
|
0.35
|
43
|
0.15
|
|
≥ 55 y/o
|
86
|
36
| |
29
| |
|
Location
|
|
U/M
|
90
|
43
|
0.98
|
37
|
0.70
|
|
L
|
79
|
41
| |
36
| |
|
Pathological T classification
|
|
T1/2
|
90
|
58
|
< 0.001*
|
48
|
< 0.001*
|
|
T3/4
|
79
|
24
| |
23
| |
|
Pathological N classification
|
|
N0
|
115
|
53
|
< 0.001*
|
45
|
< 0.001*
|
|
N1/2/3
|
54
|
19
| |
17
| |
|
Pathological 7th AJCC stage
|
|
I/II
|
123
|
52
|
< 0.001*
|
44
|
< 0.001*
|
|
III
|
46
|
15
| |
15
| |
|
Histological grading
|
|
Grade 1/2
|
125
|
46
|
0.088
|
38
|
0.18
|
|
Grade 3
|
44
|
32
| |
30
| |
|
Surgical margin
|
|
Negative
|
150
|
45
|
0.01*
|
38
|
0.02*
|
|
Positive
|
19
|
21
| |
21
| |
|
ESPN expression
|
|
Low expression
|
83
|
54
|
0.005*
|
43
|
0.035*
|
|
High expression
|
86
|
30
| |
29
| |
- AJCC American Joint Committee on Cancer
- * Statistically significant
